IDiyas

For the Inventor, By the Inventor

Columbia, MD, United States of America

Wei Wu He

USPTO Granted Patents = 18 

Average Co-Inventor Count = 3.5

ph-index = 6

Forward Citations = 160(Granted Patents)


Location History:

  • Gainesville, FL (US) (1994)
  • Columbia, MD (US) (1997 - 2006)

Company Filing History:

goldMedal16 out of 676 
 
Human Genome Sciences, Inc.
 patents
silverMedal2 out of 832,680 
Other
 patents

Years Active: 1994-2006

Loading Chart...
18 patents (USPTO):Explore Patents
1. 7026140 - Serum paraoxonase (2006-04-11),
2. 6733981 - Antibodies to interleukin-1 &bgr; converting enzyme like apoptosis protease-3 and 4 (2004-05-11),
3. 6656743 - Human choline acetyltransferase (2003-12-02),
4. 6538121 - Interleukin-1 &bgr; converting enzyme like apoptosis protease-3 and 4 (2003-03-25),
5. 6521227 - Polynucleotides encoding prostatic growth factor and process for producing prostatic growth factor polypeptides (2003-02-18),
6. 6500638 - Prostatic growth factor (2002-12-31),
7. 6495519 - Interleukin-1 &bgr; converting enzyme like apoptosis protease-3 and 4 (2002-12-17),
8. 6344198 - Human prostatic specific reductase (2002-02-05),
9. 6319700 - Human choline acetyltransferase (2001-11-20),
10. 6245540 - Human choline acetyltransferase (2001-06-12),
11. 6140093 - Polynucleotides encoding paraoxonase (2000-10-31),
12. 6106829 - Human prostatic specific reductase (2000-08-22),
13. 6087150 - Interleukin-1 .beta. converting enzyme like apoptosis protease-3 and 4 (2000-07-11),
14. 5994102 - Polynucleotides encoding prostatic growth factor and process for (1999-11-30),
15. 5792639 - Paraoxonase polypeptides and use therefor (1998-08-11),

Title: The Innovations of Wei Wu He

Introduction

Wei Wu He is a prominent inventor based in Columbia, MD (US), known for his significant contributions to the field of biochemistry and molecular biology. He holds a total of 18 patents, showcasing his innovative spirit and dedication to advancing scientific knowledge.

Latest Patents

Among his latest patents, Wei Wu He has developed a serum paraoxonase enzyme, along with the DNA (RNA) encoding such enzymes. This invention includes a procedure for producing these polypeptides through recombinant techniques. The applications of these polypeptides are critical, as they serve as an antidote for organophosphate poisoning and help prevent neuronal cell death. Additionally, he has disclosed human interleukin-1 β converting enzyme-like apoptosis proteases-3 and 4, along with their encoding DNA (RNA). This patent also details a method for producing these polypeptides and their potential uses as antitumor and antiviral agents, as well as for treating conditions such as Alzheimer's disease, Parkinson's disease, rheumatoid arthritis, and head injuries.

Career Highlights

Wei Wu He has worked with notable companies, including Human Genome Sciences, Inc. His work has significantly impacted the field of medical research and therapeutic development.

Collaborations

Throughout his career, Wei Wu He has collaborated with esteemed colleagues, including Peter L Hudson and Craig A Rosen. These partnerships have further enhanced his research and innovation efforts.

Conclusion

Wei Wu He exemplifies the spirit of innovation through his groundbreaking patents and contributions to science. His work continues to influence the fields of biochemistry and medicine, making a lasting impact on health and treatment options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…